Bayesian dose escalation with overdose and underdose control utilizing all toxicities in phase I/II clinical trials (Q6625365)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Bayesian dose escalation with overdose and underdose control utilizing all toxicities in phase I/II clinical trials |
scientific article; zbMATH DE number 7932814
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bayesian dose escalation with overdose and underdose control utilizing all toxicities in phase I/II clinical trials |
scientific article; zbMATH DE number 7932814 |
Statements
Bayesian dose escalation with overdose and underdose control utilizing all toxicities in phase I/II clinical trials (English)
0 references
28 October 2024
0 references
normalized equivalence toxicity score
0 references
overdose control
0 references
phase I/II clinical trial
0 references
underdose control
0 references
0 references
0 references
